VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue

The proposed acquisition would expand VSee’s healthcare technology platform and add a profitable commerce business if the transaction is completed.

Key Investor Takeaways

• VSee Health (NASDAQ:VSEE) signed a non-binding letter of intent to acquire healthcare technology and operating assets.
• The target business has an annual revenue run rate exceeding $35 million and approximately $7 million in EBITDA, according to the company.
• VSee said the proposed transaction is valued at approximately $42 million and is expected to close without initial shareholder dilution.
• The acquisition would broaden the company’s healthcare commerce capabilities alongside its existing telehealth platform.
• The transaction remains subject to due diligence, definitive agreements and customary approvals.

Why VSee Stock Is in Focus

VSee Health (NASDAQ:VSEE) announced it has entered into a non-binding letter of intent to acquire healthcare technology and operating assets supporting a vertically integrated healthcare commerce platform.

According to the company, the proposed acquisition is valued at approximately $42 million. The target assets currently generate an annualized revenue run rate of more than $35 million and approximately $7 million in EBITDA, although VSee noted those figures are unaudited.

The platform serves the U.S. clinic-based wellness market by connecting suppliers, commercial organizations and clinics through cloud-based ordering, payment workflows, supplier coordination and back-office operations. VSee believes these capabilities would complement its API-driven virtual care platform and expand the digital infrastructure it provides to healthcare organizations.

The company also stated that it expects the acquisition, if completed, to close relatively quickly and without initial shareholder dilution.

Why This Matters for Investors

The proposed acquisition could materially increase VSee’s scale by adding a profitable operating platform with meaningful recurring revenue.

Beyond the financial contribution, the transaction may broaden VSee’s business model by extending its reach beyond telehealth software into healthcare commerce and operational workflow management. Combining these capabilities could strengthen the company’s competitive positioning if integration proceeds successfully.

However, investors should note that the announcement relates to a non-binding letter of intent. The transaction remains subject to due diligence, negotiation of definitive agreements, regulatory and corporate approvals, and other customary closing conditions. There is no assurance that the acquisition will ultimately be completed.

What to Watch Next

Investors will likely focus on several upcoming catalysts:

• Completion of due diligence and execution of definitive acquisition agreements.
• Confirmation of the proposed purchase price and financing structure.
• Any updates regarding the expected closing timeline.
• Progress on VSee’s broader strategic review and any additional acquisitions or strategic initiatives announced by the company.

VSee Health stock price